Prof. Bo Xu
Cardiologist, Director of Cath Lab, Fuwai Hospital
"QFR is a tool that cardiologists dream of. It brings the brightness to improve the clinical pathway of PCI in China and the world and will improve the prognosis of patients."
Prof. Yuejin Yang
Cardiologist, Vice Dean, Fuwai Hospital
"QFR will be a good assessment method for critical lesions even for more severe stenotic lesions before stenting, with excellent application prospects. "
Prof. Yundai Chen
Cardiologist, Director of Cardiology Department in PLA General Hospital
"QFR is expected to be in parallel with FFR. In addition, for the three advantages of wire free, non-invasive, and fast assessment, QFR is expected to replace FFR in some clinical applications in the future. Whether QFR will become an indispensable clinical tool for cardiologists depends on further QFR clinical research."
Prof. Shaoliang Chen
Cardiologist, Vice Dean, Director of Cardiology Department in Nanjing First Hospital
"QFR requires no wire or adenosine, and can fast assess the functional significance of coronary stenosis in the Cath Lab. I believe QFR has the prospect to be a powerful tool for optimizing PCI."
Prof. Lijun Guo
Cardiologist, Peking University Third Hospital
"About 50% (about 330,000 cases per year) of the patients underwent PCI in China should have undergone coronary arterial functional evaluation. QFR examination has great clinical value for the patients whose lesions are difficult to determine."
Prof. Xinkai Qu
Director of Cardiology Dept., Shanghai Chest Hospital
"QFR, as a novel detection method for testing coronary arterial function, has the characteristics of non-invasiveness, simplicity, rapidity, and precision. It has greatly expanded the detection population and will encourage more patients to undergo functional testing, which will help guide the design of clinical strategies. The current data shows that the QFR is extremely in line with FFR, so clinical trials using QFR to guide PCI practice should be designed as soon as possible to verify its clinical application value. "
Cardiologist, Guangdong General Hospital
"QFR is not only an alternative to FFR, but also an extension of FFR indications. It avoids the interference of the guide wire and may reflect the true state of blood vessels and lesions better compared with FFR."
Prof. Hongbing Yan
Cardiologist, Fuwai Hospital
"The emergence of QFR is expected to replace FFR, becoming an excellent tool for assessing coronary arterial function before PCI surgery. It perfectly overcomes the shortcomings of FFR: poor reproducibility, poor operability, adenosine side effects, and over costs."
Thierry LeFevre , M.D.
Institut Cardiovasculaire Paris Sud, France
“Very enthusiastic about this technique, it's the future of functional testing.”-During the live case EuroPCR 2016
Christoph K. Naber , M.D., Ph.D.
University Hospital Essen,Germany
“This is the dream of every interventional cardiologist.”
-During the live case CIT 2016
William Wijns, M.D., Ph.D.
The chair, EuroPCR
QFR is a revolutionary technique for intervention. It will be used in the accurate assessment of coronary heart disease during surgery, and it will promote the value of accurate assessment in the diagnosis and treatment of coronary heart disease.
Holger olger Nef , M.D.
University Clinic Giessen, Germany
“I am very glad to have this outstanding technology.”
Pulse Medical Imaging Technology (Shanghai) CO.LTD.
402,Bld 2,No 481 Guiping Rd, Shanghai, China.
Tel: +86 21 5467 0228
Fax: +86 21 5467 0226